FACULTY
MD(Hon), MRCP(UK), FRCP(C), FACP
EOS President,
CEO Burjeel Cancer Institute,
Burjeel Holding,
Professor of Oncology,
RAK Medical & Health Sciences University, UAE
CEO Burjeel Cancer Institute,
Burjeel Holding,
Professor of Oncology,
RAK Medical & Health Sciences University, UAE
MD
Chief Medical Officer,
Burjeel Cancer Institute,
Clinical Director,
Department of Radiation Oncology, Burjeel Medical City, UAE
Burjeel Cancer Institute,
Clinical Director,
Department of Radiation Oncology, Burjeel Medical City, UAE
Head Health System Readiness and Partnership,
Novartis Radioligand Therapies,
Switzerland
MD
Medical Director of
Burjeel Cancer Institute,
Burjeel Medical City, UAE
Burjeel Medical City, UAE
Sr. Specialist,
Radiation Safety Department,
at the Federal Authority,
for Nuclear Regulation (FANR), UAE
Radiation Safety Department,
at the Federal Authority,
for Nuclear Regulation (FANR), UAE
AGENDA
Time
Chairperson
Prof. Humaid Al Shamsi
7:00-7:05 PM
Welcome & Opening Remarks
Dr. Ibrahim Abu-Gheida
7:05-7:20 PM
Head Health System Readiness and Partnership Novartis Radioligand Therapies
Leonhard Schaetz
7:20-7:35 PM
Realising the potential of RLT:
A national call for action
Dr. Hassan Jaafar
7:35-8:15 PM
Infrastructure needed for addressing Theranostics in UAE
Buthaina Al Ameri
8:15-8:55 PM
Panel Discussion:
Key Barriers and How to Overcome Them
ALL
8:55-9:00 PM
Closing Remarks
Dr. Ibrahim Abu-Gheida
GALLERY
SPONSORED BY
MANAGED BY
